Secondary Logo

Most Popular Articles

Preclinical testing of 5-amino-1-((1R,2S,3S,4R)-2,3-dihydroxy-4-methylcyclopentyl)-1H-imidazole-4-carboxamide: a potent protein kinase C-ι inhibitor as a potential prostate carcinoma therapeutic

Apostolatos, André H.; Apostolatos, Christopher A.; Ratnayake, Wishrawana S.; More

Anti-Cancer Drugs. 30(1):65-71, January 2019.

Palbociclib has no clinically relevant effect on the QTc interval in patients with advanced breast cancer

Durairaj, Chandrasekar; Ruiz-Garcia, Ana; Gauthier, Eric R.; More

Anti-Cancer Drugs. 29(3):271-280, March 2018.

DZ-2384 has a superior preclinical profile to taxanes for the treatment of triple-negative breast cancer and is synergistic with anti-CTLA-4 immunotherapy

Bernier, Cynthia; Soliman, Ahmed; Gravel, Michel; More

Anti-Cancer Drugs. 29(8):774-785, September 2018.

Dual compartmental targeting of cell cycle and angiogenic kinases in colorectal cancer models

Capasso, Anna; Pitts, Todd M.; Klauck, Peter J.; More

Anti-Cancer Drugs. 29(9):827-838, October 2018.

Complete response after rechallenge with trabectedin in a patient with previously responding high-grade undifferentiated sarcoma

Baldi, Giacomo G.; Di Donato, Samantha; Fargnoli, Rossana; More

Anti-Cancer Drugs. 27(9):908-913, October 2016.

Sodium meta-arsenite induces reactive oxygen species-dependent apoptosis, necrosis, and autophagy in both androgen-sensitive and androgen-insensitive prostate cancer cells

Kim, Yunlim; Jeong, In Gab; You, Dalsan; More

Anti-Cancer Drugs. 25(1):53-62, January 2014.

Cytotoxicity and molecular activity of fenretinide and metabolites in T-cell lymphoid malignancy, neuroblastoma, and ovarian cancer cell lines in physiological hypoxia

Song, Michael M.; Makena, Monish R.; Hindle, Ashly; More

Anti-Cancer Drugs. 30(2):117-127, February 2019.

A case of heavily pretreated metastatic cardiac angiosarcoma treated successfully using eribulin

Inagaki, Chiaki; Shimoi, Tatsunori; Okuma, Hitomi; More

Anti-Cancer Drugs. 29(1):97-101, January 2018.

Zebularine induces chemosensitization to methotrexate and efficiently decreases AhR gene methylation in childhood acute lymphoblastic leukemia cells

Andrade, Augusto F.; Borges, Kleiton S.; Castro-Gamero, Angel M.; More

Anti-Cancer Drugs. 25(1):72-81, January 2014.

In-vitro and in-vivo evaluation of the anticancer activity of diruthenium-2, a new trithiolato arene ruthenium complex [(η6-p-MeC6H4Pri)2Ru2(μ-S-p-C6H4OH)3]Cl

Muthná, Darina; Tomšík, Pavel; Havelek, Radim; More

Anti-Cancer Drugs. 27(7):643-650, August 2016.

Phase I dose-escalation study of cabazitaxel administered in combination with gemcitabine in patients with metastatic or unresectable advanced solid malignancies

Rixe, Olivier; Puzanov, Igor; LoRusso, Patricia M.; More

Anti-Cancer Drugs. 26(7):785-792, August 2015.

Reduced folate and serum vitamin metabolites in patients with rectal carcinoma: an open-label feasibility study of pemetrexed with folic acid and vitamin B12 supplementation

Stoffregen, Clemens C.; Odin, Elisabeth A.; Carlsson, Göran U.; More

Anti-Cancer Drugs. 27(5):439-446, June 2016.

Prolonged activity and toxicity of sirolimus in a patient with metastatic renal perivascular epithelioid cell tumor: a case report and literature review

Raimondi, Alessandra; Colombo, Francesca; Pintarelli, Giulia; More

Anti-Cancer Drugs. 29(6):589-595, July 2018.

Treatment of relapsed urothelial bladder cancer with vinflunine: real-world evidence by the Hellenic Genitourinary Cancer Group

Pistamaltzian, Nikolaos; Tzannis, Kimon; Pissanidou, Vassiliki; More

Anti-Cancer Drugs. 27(1):48-53, January 2016.

Show: